Re:In its fight to keep drug prices high, big pharma leans o...
by refurb on Monday April 29, 2019 @12:30PM
(#19779853)
We know because public drug manufacturers share that information. For the big companies, it's around 17-20% of revenues go into R&D.
[ Parent
| on HN ]